pre-seed
Stage
1
Investors
About
Sequence Bio uses population multi-omics data from genetically less variable populations to discover gene variants associated with diseases and works with pharma and biotech companies to identify drug targets and optimize clinical trials.
Explore Sequence Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.